Related case:
SDRCC 2019 CCES vs Graeme Thompson
October 3, 2019
In September 2019 the Canadian Centre for Ethics in Sport (CCES) has reported an anti-doping rule violation against the Athlete Graeme Thompson after his sample tested positive for the prohibited substances Clenbuterol and Tamoxifen. After notification the Athlete admitted the violation, waived his right for a hearing, accepted the provisional suspension and the sanction proposed by CCES.
The Athlete denied the intentional use of the substances and asserted that the positive test was the result of contaminated supplements he had used. Analysis in the Montreal Lab of these supplements confirmed the presence of these substances in the packages.
CCES accepts that the violation was not intentional and issued in May 2020 an amended Notification for the imposition of a reduced sanction. Here CCES considers that the substances were not listed on the labels of the supplements in question and neither an internet search would reveal the presence of these substances in these supplements. Further the Montreal Lab confirmed that the concentration of Clenbuterol found in the sample was consistent with the level detected in the Athlete's supplements.
Therefore the CCES decides on 29 May 2020 to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 October 2019.
